There are 10 resources available
Welcome and Learning Objectives
Presenter: G. Curigliano, IT and E. Smyth, UK
Session: Welcome and Introduction
Resources:
Slides
Webcast
ADC Development: What Are the Considerations in Early Phase Trials?
Presenter: M. F. Mosele, FR
Session: Session 1 – ADC Development and Pharmacodynamics
Resources:
Slides
Webcast
Mechanisms of Action and Resistance: ADC Internalization and Cleavage and Mechanisms of Resistance
Presenter: B. Pistilli, FR
Session: Session 1 – ADC Development and Pharmacodynamics
Resources:
Slides
Webcast
Toxicity: Prediction, Identification and Treatment
Presenter: E. Fontana, UK
Session: Session 1 – ADC Development and Pharmacodynamics
Resources:
Slides
Webcast
How to Revelop Rationale Combinations and Sequencing
Presenter: G. Curigliano, IT
Session: Session 2 – Target Assessment and Rationale for Combinations
Resources:
Slides
Webcast
Considerations from Pathology: Biomarker Selection, On-Target, Off-Tumour Expression, Off-Target Toxicities
Presenter: G. Pruneri, IT
Session: Session 2 – Target Assessment and Rationale for Combinations
Resources:
Slides
Webcast
Developments in ADC Constructs Including Bispecific ADCs
Presenter: E. Fontana, UK
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast
Cytokine Conjugates
Presenter: A. Sartore Bianchi, IT
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast
Peptide-Based Conjugates
Presenter: E. Smyth, UK
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast
Therapeutic Index and Rationale for ADCs Sequencing
Presenter: B. Pistilli, FR
Session: Session 3 – Next Generation ADCs
Resources:
Slides
Webcast